Jbog--Thanks for your insights. Clearly, there is a lot cooking in the pipeline, and I look forward to watching the pipeline develop. IMO, the pipeline is still underappreciated. In the near term the investment community seems most focused on ASCO and FLEX data rather than on the pipeline.
Regards,
biophud
PS Thanks for the investment report that you sent via private communication. Lately I have not been doing well enough in my biotech investments for the premium iHUB subscription :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.